Mon. 6 May 2024, 7:01am ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(1.44) per share which missed the analyst consensus estimate of $(1.21) by 19.01 percent. The company reported quarterly sales of $74.999 million which beat the analyst consensus estimate of $73.295 million by 2.32 percent. This is a 20.70 percent decrease over sales of $94.576 million the same period last year.